Afib Drug Gets a Chance to Exit Regulatory Limbo

]]>(MedPage Today) -- More than a decade since its first shot at FDA approval, vernakalant injection will once again face an advisory panel for an indication in rapid conversion of recent-onset atrial fibrillation (Afib).The agency's Cardiovascular...